JeffreyJohnMeyerMD

Radiation Oncology • Baltimore, MD

Associate Professor, Johns Hopkins

Join to view full profile

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

Office
401 North Broadway Street
Weinberg Building, Floor-L2
Baltimore, MD 21287
Phone+1 410-955-6980

Fax+1 410-502-1419

Education & Training

Duke University HospitalResidency, Radiation Oncology, 2004 - 2008
Cedars-Sinai Medical CenterInternship, Internal Medicine, 2003 - 2004
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

DC State Medical License 2019 - 2027
TX State Medical License 2009 - 2026
MD State Medical License 2017 - 2025
NC State Medical License 2020 - 2022
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases Start of enrollment: 2010 Jul 01
Completed
Phase 1
Circulating Tumor Cells in Prostate Cancer Patients Start of enrollment: 2011 Jul 01
Terminated
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma Start of enrollment: 2012 Aug 08
Completed
Phase 1

Publications & Presentations

PubMed

Routine review of patient-reported outcome data influences radiotherapy care: IMPROVE study results.
Khinh Ranh Voong, Siyao Li, Chen Hu, Ori Shokek, Russell K Hales
Radiotherapy and Oncology. 2025-02-01
Durable Response to Combined Nivolumab, Lenvatinib, and Radiation Therapy Against Oligometastatic Hepatocellular Carcinoma.
Sewoon Chun, Erin M Coyne, Jeffrey Meyer, Won Jin Ho
Cureus. 2024-11-01
1 citations
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith
Cancer Research Communications. 2024-08-01

Press Mentions

Stereotactic Radiation Highly Effective for Kidney CancerMay 4th, 2017